Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via RCPCH
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via RCPCH
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 109, Issue 4
Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5–6 years
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original research
Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5–6 years
Online download statistics by month:
Online download statistics by month: January 2024 to September 2024
Abstract
Full
Pdf
Jan 2024
1004
91
46
Feb 2024
336
38
23
Mar 2024
201
23
12
Apr 2024
270
27
16
May 2024
218
13
5
Jun 2024
423
35
18
Jul 2024
405
43
25
Aug 2024
247
27
15
Sep 2024
134
24
11
Total
3238
321
171
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via RCPCH
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF